Medical Device Contract Manufacturing Market To Reach $214.33 Billion By 2033

Medical Device Contract Manufacturing Market Growth & Trends

The global medical device contract manufacturing market size is expected to reach USD 214.33 billion by 2033, registering a CAGR of 12.58% from 2026 to 2033, according to a new report by Grand View Research, Inc. Market growth can be attributed to benefits offered to medical device companies, such as cost savings, scalability, growing adoption of technology, rising focus on quality assurance, and the ability to focus on core competencies.

Outsourcing manufacturing processes to contract manufacturers supports medical device companies to focus on their core competencies, such as R&D, product design, and marketing. Besides, the growing adoption of robotics and AI-driven automation, which support enhanced precision, scalability, and efficiency, is expected to drive market growth. In addition, medical devices focus on innovation from design to deployment; prototype technologies such as computer-aided design (CAD) software, 3D printing, and software allow for rapid testing and iteration. Likewise, the automation testing process ensures quality checks that are frequent and consistent.

Contract manufacturing continues to refine its operations to serve the evolving needs of device OEMs better. A contract manufacturer often supports highly skilled and knowledgeable experience about the latest medical device technologies, processes, and innovations. These OEMs benefit from the contract manufacturer’s existing expertise. This supports companies stay competitive and updated on state-of-the-art production techniques without significant investment.

The rising demand for portable, complex medical devices to address unmet medical needs has boosted the market. Besides, the requirement for single-use and disposable devices is increasing, leading to increased attraction in diagnostics and infection control. Technologies like wearable and IoT-enabled devices can drastically drive the market growth in electronics and micro-manufacturing.

The regulation is one of the significant factors for medical device companies that have fueled the demand for medical device contract manufacturing. The FDA plays a pivotal role in ensuring the safety and efficiency of medical devices in the market. Besides, Medical device contract manufacturers must comply with the QSR, 21 CFR Part 820, which outlines the current Good Manufacturing Practices (cGMP) for medical devices.

Strategic partnerships and co-development models between OEMs and contract manufacturers are streamlining supply chains and accelerating product launches. In addition, the growing focus on patient-specific and personalized devices is boosting demand for customized medical devices. For instance, in June 2024, Donatelle Plastics Incorporated, a medical device contract manufacturer in designing, developing, and manufacturing medical components and devices, was acquired by DuPont. The acquisition will bring advanced technologies & capabilities, including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, & tool building.

 Request a free sample copy or view report summary: Medical Device Contract Manufacturing Market Report

Medical Device Contract Manufacturing Market Report Highlights

• The medical device contract manufacturing market presents significant growth opportunities driven by increasing demand for advanced, personalized, and digitally integrated devices.

• Tariffs and import/export duties are transforming the medical device contract manufacturing market by increasing input costs and disrupting global supply chains.

• Technological advancements are transforming the medical device contract manufacturing market, driven by the increasing adoption of smart manufacturing and Industry 4.0 solutions.

• The medical device contract manufacturing employs diverse pricing models to balance cost control, flexibility, and risk-sharing. Milestone-based pricing ties payments to predefined deliverables, offering cost certainty for well-defined projects but limited flexibility and potential risk premiums.

• The medical device contract manufacturing employs diverse pricing models to balance cost control, flexibility, and risk-sharing. Milestone-based pricing ties payments to predefined deliverables, offering cost certainty for well-defined projects but limited flexibility and potential risk premiums.

• On the basis of product segment, the class II segment led the medical device contract manufacturing market and accounted for 80.10% of global revenue in 2025.

• On the basis of the service, the accessories manufacturing segment dominated the market in 2025, due to rising demand for highly customized surgical instruments, precision-driven designs, and efficient development-to-production workflows.

• On the basis of the therapeutic area, the cardiovascular device segment dominated the market in 2025. The adoption of robotic-assisted Coronary Artery Bypass Grafting (CABG) is driving a shift toward minimally invasive cardiovascular procedures, increasing demand for advanced devices such as robotic instruments, precision catheters, and specialized implants.

• On the basis of end use, the OEM segment held the largest revenue share in 2025, driven by its central role in innovation, commercialization, and large-scale device production. OEMs generate significant outsourcing demand by relying on specialized manufacturers to manage complex development processes, regulatory compliance, and cost pressures.

• Asia Pacific dominated the global medical device contract manufacturing market in 2025, holding a revenue share of 41.54%. The growth of this region is due to high-volume production and high-value device development outsourcing dynamics across its major economies.

Medical Device Contract Manufacturing Market Segmentation

Grand View Research has segmented the global medical device contract manufacturing market based on product, services, therapeutic area, end use and region:

Medical Device Contract Manufacturing Product Outlook (Revenue, USD Million, 2021 - 2033)

• Class I

• Class II

• Class III

Medical Device Contract Manufacturing Service Outlook (Revenue, USD Million, 2021 - 2033)

• Accessories Manufacturing

• Assembly Manufacturing

• Component Manufacturing

• Device Manufacturing

• Packaging and Labeling

• Others

Medical Device Contract Manufacturing Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)

• Cardiovascular Devices

• Orthopedic Devices

• Ophthalmic Devices

• Diagnostic Devices

• Respiratory Devices

• Surgical Instruments

• Dental

• Others

Medical Device Contract Manufacturing End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Original Equipment Manufacturers (OEMs)

• Pharmaceutical & Biopharmaceutical Companies

• Others

Medical Device Contract Manufacturing Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Oman

  • Qatar

List of Key Players in the Medical Device Contract Manufacturing Market

• Jabil Inc.

• Thermo Fisher Scientific Inc.

• Integer Holdings Corporation

• FLEX LTD.

• Sanmina Corporation

• Celestica Inc.

• Phillips-Medisize

• Plexus Corp.

• Nipro Corporation

• Viant Technology LLC

• West Pharmaceutical Services, Inc.

• Mack Molding

• Cirtec Medical

• Cogmedix

• Synecco Ltd

• TE Connectivity

• Keller Technology Corp.

• HDA Technology, Inc.